Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS ...

Mitochondrial genome mutations may be linked to ALS, per a study, opening the door for new ways to diagnosing and treating ...

The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease. An ALS specialist ordered Bill a DNA test. While he waited for results, he ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...